Asarina Pharma AB (publ) (ASAP.ST)

SEK 0.03

(-31.03%)

Total Debt Summary of Asarina Pharma AB (publ)

  • Asarina Pharma AB (publ)'s latest annual total debt in 2023 was 1 Million SEK , down 0.0% from previous year.
  • Asarina Pharma AB (publ)'s latest quarterly total debt in 2023 FY was 1 Million SEK , down 0.0% from previous quarter.
  • Asarina Pharma AB (publ) reported annual total debt of - SEK in 2022, down -100.0% from previous year.
  • Asarina Pharma AB (publ) reported annual total debt of 5.3 Million SEK in 2021, down 0.0% from previous year.
  • Asarina Pharma AB (publ) reported quarterly total debt of - SEK for 2023 Q2, down 0.0% from previous quarter.
  • Asarina Pharma AB (publ) reported quarterly total debt of - SEK for 2023 Q1, down 0.0% from previous quarter.

Annual Total Debt Chart of Asarina Pharma AB (publ) (2023 - 2017)

Historical Annual Total Debt of Asarina Pharma AB (publ) (2023 - 2017)

Year Total Debt Total Debt Growth
2023 1 Million SEK 0.0%
2022 - SEK -100.0%
2021 5.3 Million SEK 0.0%
2020 - SEK 0.0%
2019 - SEK 0.0%
2018 - SEK 0.0%
2017 - SEK 0.0%

Peer Total Debt Comparison of Asarina Pharma AB (publ)

Name Total Debt Total Debt Difference
Alligator Bioscience AB (publ) 16.09 Million SEK 93.788%
Ziccum AB (publ) 857 Thousand SEK -16.686%
Modus Therapeutics Holding AB (publ) - SEK -Infinity%
BioArctic AB (publ) 4.97 Million SEK 79.916%
Sprint Bioscience AB (publ) - SEK -Infinity%
Mendus AB (publ) 24.48 Million SEK 95.916%
Genovis AB (publ.) 79.32 Million SEK 98.739%
Intervacc AB (publ) 181 Thousand SEK -452.486%
QuiaPEG Pharmaceuticals Holding AB (publ) 20.61 Million SEK 95.148%
Active Biotech AB (publ) 3 Million SEK 66.667%
Magle Chemoswed Holding AB (publ) 60.3 Million SEK 98.342%
Bio-Works Technologies AB (publ) - SEK -Infinity%
Aptahem AB (publ) 5 Million SEK 80.0%
Vicore Pharma Holding AB (publ) - SEK -Infinity%
Kancera AB (publ) - SEK -Infinity%
Infant Bacterial Therapeutics AB (publ) - SEK -Infinity%
Fluicell AB (publ) - SEK -Infinity%
Saniona AB (publ) 71.4 Million SEK 98.6%
Lipigon Pharmaceuticals AB (publ) - SEK -Infinity%
Biovica International AB (publ) 7.82 Million SEK 87.225%
Spago Nanomedical AB (publ) - SEK -Infinity%
AcouSort AB (publ) - SEK -Infinity%
Xintela AB (publ) - SEK -Infinity%
Abliva AB (publ) 424 Thousand SEK -135.849%
Egetis Therapeutics AB (publ) 108.6 Million SEK 99.079%
Karolinska Development AB (publ) 3.07 Million SEK 67.427%
OncoZenge AB (publ) - SEK -Infinity%
Amniotics AB (publ) 2.58 Million SEK 61.24%
2cureX AB (publ) - SEK -Infinity%
CombiGene AB (publ) - SEK -Infinity%
Calliditas Therapeutics AB (publ) 979.13 Million SEK 99.898%
Camurus AB (publ) 24.5 Million SEK 95.92%
Corline Biomedical AB - SEK -Infinity%
IRLAB Therapeutics AB (publ) 27.56 Million SEK 96.372%
Isofol Medical AB (publ) - SEK -Infinity%
I-Tech AB - SEK -Infinity%
Hansa Biopharma AB (publ) 866.76 Million SEK 99.885%
Cyxone AB (publ) 858 Thousand SEK -16.55%
ExpreS2ion Biotech Holding AB (publ) 1.71 Million SEK 41.555%
Biosergen AB - SEK -Infinity%
Cantargia AB (publ) - SEK -Infinity%
NextCell Pharma AB - SEK -Infinity%
Xspray Pharma AB (publ) 36.8 Million SEK 97.283%
Elicera Therapeutics AB (publ) - SEK -Infinity%
Nanologica AB (publ) 666 Thousand SEK -50.15%
SynAct Pharma AB 637 Thousand SEK -56.986%
Annexin Pharmaceuticals AB (publ) - SEK -Infinity%
Stayble Therapeutics AB (publ) 850 Thousand SEK -17.647%
LIDDS AB (publ) - SEK -Infinity%
Lipum AB (publ) 1.76 Million SEK 43.214%
BioInvent International AB (publ) 23.24 Million SEK 95.698%
Alzinova AB (publ) 800 Thousand SEK -25.0%
Oncopeptides AB (publ) 106.48 Million SEK 99.061%
Pila Pharma AB (publ) 773.08 Thousand SEK -29.353%
Guard Therapeutics International AB (publ) - SEK -Infinity%
Scandinavian ChemoTech AB (publ) - SEK -Infinity%
Simris Alg AB (publ) 90.74 Million SEK 98.898%
Diamyd Medical AB (publ) 30.67 Million SEK 96.74%
Xbrane Biopharma AB (publ) 231.47 Million SEK 99.568%
Ascelia Pharma AB (publ) 1.06 Million SEK 5.749%
Diagonal Bio AB (publ) - SEK -Infinity%